Spring 2025 Comment on the USSC
The United States Sentencing Commission (USSC) had an opportunity during this most recent amendment cycle to make significant and meaningful changes to the Sentencing Guidelines that would at least begin …
MAPS in the Media
MAPS Announces MDMA-Assisted Therapy Education Event For Ukrainian Mental Health Practitioners
April 15, 2025 — The Multidisciplinary Association for Psychedelic Studies (MAPS), a 501(c)(3) nonprofit organization at the vanguard of the psychedelic movement since 1986, is bringing its International …
Psychedelic Science 2025 Announces Select Speakers for the Leading Conference on Psychedelic Research, Policy, and Thought Leadership
March 7, 2025 — Psychedelic Science — the premier global gathering for psychedelic research, medicine, policy, and culture hosted by the Multidisciplinary Association for Psychedelic Studies (MAPS) …
MAPS Releases Template to Assist in Federal Drug Sentencing Reform Efforts
Washington D.C.; February 27, 2025 — The Multidisciplinary Association for Psychedelic Studies (MAPS), a 501(c)(3) nonprofit organization that has led the psychedelic movement since 1986, has released …
MAPS Announces Search for New Executive Director as it Doubles Down on Advocacy and Movement Building
FOR IMMEDIATE RELEASE: February 12, 2025 The Multidisciplinary Association for Psychedelic Studies (MAPS), a 501(c)(3) nonprofit organization that has led the psychedelic movement since 1986, today announced …
FDA authorizes clinical trials to study cannabis use for veterans with PTSD | Stars and Stripes
Weed for PTSD? Eager for Better Cannabis Science, F.D.A. Clears Study. | The New York Times
MAPS Successfully Clears Path for Cannabis Research through FDA Formal Dispute
FOR IMMEDIATE RELEASE: November 20, 2024 The U.S. Food and Drug Administration (FDA) Division of Psychiatry Products has cleared the Multidisciplinary Association for Psychedelic Studies (MAPS)’ Phase …
Setback Or Opportunity? FDA Rejects MDMA For PTSD | Forbes
Despite FDA setback, psychedelic pioneer Rick Doblin is unfazed about MDMA’s prospects – The Washington Post
MAPS Awards Grant for Pilot MDMA-assisted Massed Exposure Therapy Trial
FOR IMMEDIATE RELEASE: August 27, 2024 The Multidisciplinary Association for Psychedelic Studies (MAPS) awarded Emory University researchers a $200,000 grant for a pilot study examining MDMA-assisted Massed …